Discover 1,272 paid clinical trials in Mesa, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,272
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Scottsdale AZ, Phoenix AZ, Glendale AZ, Chula Vista CA,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase3, Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
for
Acute Myeloid Leukemias
Location: Goodyear AZ, Duarte CA, Shreveport LA, Toronto,
Sponsor: Syndax Pharmaceuticals
Sex: All
Age: 12+
Code: NCT07211958
Phase3, Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohn Disease
Location: Sun City AZ, Murrieta CA, Salt Lake City UT,
Sponsor: Abivax S.A.
Sex: All
Age: 18 - 70+
Code: NCT06456593
Phase2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Scottsdale AZ, Las Vegas NV, San Diego CA, La Mesa CA,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase1, Phase2, Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for
Clostridoides Difficile Associated Disease
Location: Sun City AZ, Chinle AZ, Gallup NM, Shiprock NM,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT07282665
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
for
Psoriatic Arthritis
Location: Sun City AZ, Tucson AZ, Riverside CA, Tujunga CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07486960
Phase2, Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease